Phenylhydrazines
Medchemexpress LLC Palonosetron hydrochloride (Standard) | 135729-62-3 | C19H25ClN2O | 100 MG
Palonosetron hydrochloride is an analytical standard intended for research and analytical applications. This compound acts as a 5-HT3 antagonist, primarily used to prevent acute, delayed, and overall chemotherapy-induced nausea and vomiting. It also demonstrates moderate anti-flavivirus activity, potent anti-Zika virus activity in mammalian cells, and possesses antidepressant activity.
- Analytical standard for research and analytical applications
- Functions as a 5-HT3 antagonist
- Primarily used to prevent chemotherapy-induced nausea and vomiting
- Shows moderate anti-flavivirus activity
- Exhibits potent anti-Zika virus activity in mammalian cells
- Possesses antidepressant activity
- Suitable for qualitative, quantitative, and methodological research experiments including HPLC, GC, and MS
Medchemexpress LLC Halofantrine hydrochloride | 36167-63-2 | 99.90% | C26H31Cl3F3NO | 1 ML
Halofantrine hydrochloride | 36167-63-2 | 99.90% | C26H31Cl3F3NO | 1 ML
Medchemexpress LLC Ligustrazine hydrochloride | 76494-51-4 | 25 MG
Ligustrazine hydrochloride is a natural product primarily utilized for research. It has shown a protective effect on injured ECV304 cells, significantly increasing NOS and NO formation. This compound is intended for research use only, not for patient or medical applications.
- Protective effect on injured ECV304 cells
- Significantly increases NOS and NO formation
- Suitable for research applications
- Solid storage at 4°C, sealed and away from moisture
- In-solvent storage at -80°C for 6 months or -20°C for 1 month
eMolecules 6971-45-5 | (2-METHOXYPHENYL)HYDRAZINE HYDROCHLORIDE | AstaTech | MFCD00035456 | 174.630 | C7H11ClN2O | 95.000 | Cl.COc1ccccc1NN | 25g | 451911236
(2-METHOXYPHENYL)HYDRAZINE HYDROCHLORIDE | AstaTech | 6971-45-5 | MFCD00035456 | 174.630 | C7H11ClN2O | 95.000 | Cl.COc1ccccc1NN | 25g | 451911236
Medchemexpress LLC Cdk4/6-in-15 | 00-00-0 | 99.3% | 442.56 g/mol | C21H27FN8S | 5 MG
CDK4/6-IN-15 is an orally active, selective inhibitor of cyclin-dependent kinases CDK4 and CDK6 used in cellular and biochemical research to probe cell-cycle regulation and anticancer activity. It arrests cells in G1, suppresses Rb phosphorylation, and has demonstrated antiproliferative and pro-apoptotic effects in multiple cell lines.
- selective inhibitor of CDK4 and CDK6 with potent activity
- arrests the cell cycle at G1 and reduces Rb phosphorylation
- demonstrated antiproliferative and pro-apoptotic effects in cell assays
- soluble in DMSO with stock preparation guidance for common concentrations
- stable when protected from light; storage recommendations provided